Chi-Su Yoon Selected Research

Chi-Su Yoon Research Topics

6	Neuroinflammatory Diseases 07/2021 - 02/2016
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2014
2	Inflammation (Inflammations) 04/2016 - 04/2016
1	Neoplasms (Cancer) 01/2021
1	Necrosis 01/2021
1	Pancreatitis 10/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Glomerulonephritis 01/2017
1	Brain Injuries (Brain Injury) 10/2015
1	Hemiplegia (Spastic Hemiplegia) 01/2015

2	Therapeutic UsesIBA 07/2021 - 10/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 02/2016
1	InterleukinsIBA 01/2021
1	CytokinesIBA 01/2021
1	nardostachinIBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	Amylases FDA Link 10/2019
1	CeruletideIBA 10/2019
1	Lipase (Acid Lipase)FDA Link 10/2019
1	Narchinol BIBA 01/2019
1	desoxonarchinol AIBA 01/2019
1	cudraflavanone AIBA 12/2018
1	hexamethylenetriperoxidediamineIBA 01/2018
1	Connective Tissue Growth FactorIBA 01/2017
1	CollagenIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	xanthoneIBA 09/2016
1	cudratricusxanthone AIBA 09/2016
1	p38 Mitogen-Activated Protein KinasesIBA 09/2016
1	LipopolysaccharidesIBA 09/2016
1	Heme Oxygenase-1IBA 04/2016
1	griseusrazin AIBA 04/2016
1	Glutamic Acid (Glutamate)FDA Link 04/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016
1	TMC 256C1IBA 04/2016
1	myrrh resin (myrrh)IBA 01/2015
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2014

2	Therapeutics 01/2017 - 10/2015